Outcome of the Open Market Consultation


OMC webinars and questionnaires provided valuable insights from patients, users and Solution ProvidersSeveral OMC events were held between March and June 2021 to help refine the clinical, patient and technical needs with respect to NGS workflows. In addition to the webinars on the Tendering Process and the Partnering Platform, several questionnaires, addressing the clinical and

Tendering Process explained by Kurt Zatloukal – view the webinar recording, presentation, and Questions & Answers


At the webinar on the Tendering Process, which was held on the 28th of April and was attended by up to 94 participants, Coordinator Kurt Zatloukal gave a presentation and answered questions about the project and the PCP process, including details regarding the evaluation criteria which should help potential solution providers prepare their bids. View

Open Market Consultation attended by over 175 attendees – view the presentations given on 22nd-23rd March 2021


Virtual Open Market Consultation event attracts widespread interest The 2-day virtual Open Market Consultation event held on the 22nd and 23rd March 2021 attracted a large amount of interest and was attended by up to 178 registrants from 31 countries. Button: Read more (presentations available) Participants included stakeholders from industry (the biotech, bioinformatics and pharmaceutical

Instand-NGS4P Coordinator to speak at Precision Diagnostics Europe, 26-28 May 2021


26 – 28 May 2021 We are pleased to draw your attention to this highly relevant conference taking place at the end of May, at which the Coordinator of Instand-NGS4P, Kurt Zatloukal, will be speaking on the pre-analytical requirements for in vitro diagnostic medical devices. DEADLINES Abstract submission deadline:        April 30 2021 Registration deadline:

View the State of the Art Lectures on NGS in Healthcare, 26th January


At the opening public session of the Instand-NGS4P Consortium Meeting, Ivo Gut (CNAG-CRG, Spain) and Sir Mark Caulfield (Genomics England) gave a fascinating insight into the impressive progress being made in the field of NGS in Healthcare: Ivo Gut talked about “Experiences with Good Genomic Practice”, and this was followed by Sir Mark Caulfield´s talk

Instand-NGS4P State of the Art Lectures on NGS in Healthcare


  Ivo Gut (CNAG-CRG, Spain) “Experiences with Good Genomic Practice” Sir Mark Caulfield (Genomics England, UK) “100,000 Genomes: Transforming healthcare” When: January 26th 2021, 13:00 – 14:50 CET Where: View the lectures here: https://drive.google.com/file/d/1AUk9jVM5Y0j897KbuLeSptw_IXp_Unxz/view?usp=sharing Attendance is free.  A recording will be available on the project website after the event: https://www.instandngs4p.eu/ INSTAND-NGS4P is an EU-funded Pre-Commercial

Further liaisons established with CEN and ISO Technical Committees


CEN/TC 140 covers standardization in the field of in vitro diagnostic medical devices, and ISO/TC SC1 handles Genomics Informatics. The newly established liaisons with these two committees will enable the project to benefit from access to the relevant standards which are in development. Instand-NGS4P plans to submit a new work item proposal to CEN/TC 140

Florence, October 7, 2020. ISPRO meets Instand-NGS4P


The EU-Instand-NGS4P project presentation at the Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO). The Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO) is a body of the Tuscany Regional Health Service whose purpose is to promote, measure and study primary, secondary and tertiary actions for cancer prevention and